DrugPatentWatch Database Preview
Tolmar Therap Company Profile
What is the competitive landscape for TOLMAR THERAP, and when can generic versions of TOLMAR THERAP drugs launch?
There are ten US patents protecting TOLMAR THERAP drugs.
There are sixty-seven patent family members on TOLMAR THERAP drugs in twenty-six countries.
Summary for Tolmar Therap
| International Patents: | 67 |
| US Patents: | 10 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 4 |
| Patent Litigation for Tolmar Therap: | See patent lawsuits for Tolmar Therap |
Drugs and US Patents for Tolmar Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021343-001 | Jan 23, 2002 | RX | Yes | Yes | 6,773,714 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | RX | Yes | Yes | 6,626,870 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | RX | Yes | Yes | 6,626,870 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021731-001 | Dec 14, 2004 | RX | Yes | Yes | 6,626,870 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Tolmar Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | 5,599,552 | ➤ Sign Up |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | 5,739,176 | ➤ Sign Up |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021343-001 | Jan 23, 2002 | 5,733,950 | ➤ Sign Up |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021343-001 | Jan 23, 2002 | 5,739,176 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Tolmar Therap
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,143,314 | Controlled release liquid delivery compositions with low initial drug burst | ➤ Sign Up |
| 6,630,155 | Controlled release liquid delivery compositions with low initial drug burst | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Tolmar Therap Drugs
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
